Searched for
PFIZER PRODUCTS INDIA
Regulator, cos discuss price hike for some cancer drugsIndia's drug pricing authority may soon approve a price hike for vital platinum-based cancer medicines. These drugs, including carboplatin ...- From oncology to obesity, Pfizer bets big on India for its next growth wavePfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- Pfizer recalls three anti-bacterial injections in India manufactured by Astral SteriTechThe company was informed by its contract manufacturer in India, Astral, that it has observed an out-of-specification during a routine envir...
- Pfizer suspends sale & use of some popular products in India due to technical issuesIn a letter written to stockists, distributors and hospitals across India, Pfizer has asked for temporary suspension of sale and distributi...
- Dr Reddy's acquires trademark rights of breast cancer drug Primcyv from Pfizer to use in IndiaPrimcyv is a targeted therapy containing the active constituent palbociclib, a first-in-class CDK 4/6 inhibitor indicated in combination wi...
- Pfizer may offer Covid antiviral drug to India at lower price for nowPfizer has entered into advance purchase agreements with multiple countries. Sources told ET that Pfizer is yet to apply for emergency use ...
- Pfizer wants to make vaccine in India if faster clearance, export freedom assured: SourcesThe U.S. company pulled an application last month seeking emergency approval for its product in India after the drug regulator declined its...
- Mylan deal to give a boost to Pfizer’s India business: AnalystsOn Monday, Pfizer and Mylan announced that as per the Reverse Morris Trust transaction, each Mylan share would be converted into one share ...
- CCI approves GSK, Pfizer consumer healthcare JV formationAfter the deal, GSK will have a majority controlling equity interest of 68 per cent in the combined consumer healthcare business.
- GSK-Pfizer combo likely to be booster dose for brands in IndiaGSK and Pfizer said on Wednesday they will merge their consumer healthcare businesses, which have combined sales of $12 billion, by creatin...
- Pfizer plans to bring more global drugs to IndiaAlthough the company sells most of its top 20 global products in India, it is looking to bring in a couple of drugs, the patents of which h...
- CCI approves Nestle's acquisition of Pfizer nutrition businessCompetition watchdog CCI has approved Nestle's proposed acquisition of the global nutrition business of Pfizer.
- Natco seeks Pfizer nod for drug cloneIndian Pharma Co claims it can sell HIV drug at one-fifth the price.
- HC provides relief to Pfizer on trade mark battle over COREXOn a plea by global pharma major Pfizer, the Delhi High Court today restrained Ahmedabad-based Stallion Laboratories from manufacturing and...
- Biocon seals Rs 1,550 cr pact with PfizerThe agreement includes the commercialisation of Biocon’s biosimilar versions of insulin and insulin analog products: recombinant human insu...
- Pfizer to continue recruitment drivePfizer India will hire an additional 200 people in the next few months and will continue to increase its headcount because it sees minimal ...
- Pfizer to license generics from India's AurobindoPfizer Inc has agreed to license an array of generic pills and injectable medicines from India's Aurobindo Pharma Ltd as the world's larges...
- Wyeth to boost Pfizer's share in Indian marketPfizer's $68-billion buyout of Wyeth may help catapult its local subsidiary into the top ten league of Indian drugmakers.
- J&J takes over Pfizer’s OTC unitThe acquisition of Pfizer’s global over-the-counter (OTC) business by Johnson & Johnson (J&J) will have some impact on Pfizer India, though...
Load More
